Har sector me roz ek deep opportunity: duniya ki asli development problem, technology kahan atki hai, scientists kya try kar rahe hain, aur India ke liye kya mauka hai. Neeche poori scored list (176 ideas) aur 8 free PDF reports. Scores model hain (andaaza), advice nahi.
8sectors, 1 deep report each per day
3deep reports live (latest per sector)
176scored ideas (152 export, 24 inside India)
142with 2+ checked reports
8free PDF summaries
13 Nov 2026list last re-scored
Aaj ki opportunities · 14 Nov 2026
Ek sector, ek deep report, roz. Har report me facts aur analysis alag label hain, aur har fact ka source link aur date hai.
Export & Manufacturing · Export aur nirmaan
Is sector ki deep report agle daily run me aayegi
Har report tabhi chhapti hai jab har fact ka source khul kar check ho jaaye.
Teaching robots to use their hands: real-world robot data and factory robot cells from India
Robots still fail at everyday hand skills because there is too little real-world movement data. India's people and growing factories can supply both data and robot set-up work.
Drug-resistant infections: fast tests and new antibiotics, with India at the centre
Antibiotics are failing fastest in South Asia, new drugs are scarce, and doctors lack quick tests. India has shown it can discover a new antibiotic; the bigger near-term gap is fast diagnosis.
Where it is stuck: Research: the problem is understood, the fix is not standard yet
Scientists kahan atke hain
FactA 2025 paper from OpenAI and Georgia Tech argues that language models 'hallucinate' because training and evaluation reward guessing over admitting uncertainty. Most popular benchmarks give no credit for 'I don't know'.[S3]
FactThe same paper points to exams with negative marking, including India's JEE, NEET and GATE, as the model for fixing this: tell the model the penalty for a wrong answer, so guessing stops paying.[S3]
Abhi kya try ho raha hai
FactResearchers propose 'confidence targets': each test question states how much a wrong answer costs, so a model is scored for knowing when to abstain.[S3]
FactThe IndiaAI Mission (outlay Rs 10,371.92 crore, approved 7 March 2024) has picked 20 indigenous foundation-model proposals from 506 applications, sanctioned 93.18 lakh GPU hours to 237 projects, and selected 13 'Safe & Trusted AI' projects on bias, machine unlearning, privacy, algorithm auditing and explainability.[S4]
Where it is stuck: Lab demos and narrow pilots; not reliable outside the lab
Scientists kahan atke hain
FactThe Open X-Embodiment project assembled one dataset from 22 different robots through a collaboration of 21 institutions, covering 527 skills (160,266 tasks); a model trained on it (RT-X) improved several robots by sharing experience across platforms.[R3]
AnalysisEven this pooled dataset is small next to the web-scale text and image data behind language and vision models, which is why real-world robot data is the bottleneck.
Abhi kya try ho raha hai
FactLabs are collecting data three ways (remote-control 'teleoperation', videos of people, and real deployments), and some are betting on 'world models' that predict physics. Physical Intelligence reported early signs that its π0.7 model can combine learned skills for tasks it was not trained on (April 2026).[R4]
FactGig workers in India and Nigeria are paid to record household chores with phones strapped to their heads; one firm (Micro1) hires thousands of contract workers in 50+ countries. Its CEO estimates robotics companies spend over US$100 million a year buying such real-world data. Privacy and consent questions are open.[R5]
Where it is stuck: Science advancing, but the drug pipeline is thin and frontline tests are missing
Scientists kahan atke hain
FactWHO's 2025 pipeline review: antibacterials in clinical trials fell from 97 (2023) to 90. Only 15 are innovative and only 5 work against at least one 'critical' priority bacterium. Of 17 new antibacterials approved since July 2017, only 2 are a new chemical class.[H4]
FactThe early-stage pipeline (232 programmes) is fragile: 90% of the companies involved are small firms with fewer than 50 employees.[H4]
Abhi kya try ho raha hai
FactWHO counts 40 'non-traditional' antibacterial approaches in trials, such as bacteriophages, antibodies and microbiome-modulating agents.[H4]
FactIndia's first indigenously developed antibiotic, nafithromycin (brand Miqnaf, by Wockhardt with support from DBT's BIRAC), took 14 years and Rs 500 crore; it is a 3-day treatment for drug-resistant community pneumonia. PIB notes India bears 23% of the world's community pneumonia burden.[H5]
Products India bahar bech sakta hai (Export from India) aur India ke andar services (Inside India). Search, sector group, country aur India angle se filter karo. Re-scored weekly.
Loading the list…
Deep-dive PDF reports (8)
Free 1-page summaries on where Indian exporters can sell: top 5 markets by our score. Data checked on 17 Oct 2026. Full market tables and every source: market tables page.
Product · HS 091030
Turmeric
Dried turmeric and turmeric powder, a spice where India is already the main supplier in most markets.
Top 5 markets: Malaysia, Bangladesh, France, Indonesia, Spain
Score. Five ratings from 0 to 5 (problem proof, demand lasts, low competition, easy entry, India fit) with fixed weights: round((0.25*P + 0.25*D + 0.25*C + 0.10*E + 0.15*I) / 5 * 100). Cuts only come from a dated, linked source. Time alone never lowers a score. Fact vs Analysis.Fact = a sourced statement, with the link and the date we opened it. Analysis = NitiMarg's reading of those facts, which can be wrong. Old links. /reports/ and /opportunities/all/ now open this page (at #reports and #all). PDF links like /reports/summary-turmeric.pdf keep working. The 7 weekly sector stories move to /opportunities/sectors/. Educational, not investment or business advice.